Raymond James Financial
NEO icon

Raymond James Financial’s NeoGenomics NEO Stock Holding History

Raymond James Financial’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-46,903
Closed -$343K – 6091
2025
Q2 		$343K Sell
46,903
-2,866
-6% -$23.1K ﹤0.01% 4222
2025
Q1 		$472K Sell
49,769
-1,137
-2% -$14.2K ﹤0.01% 3965
2024
Q4 		$839K Buy
+50,906
New +$791K ﹤0.01% 3569

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Raymond James Financial's NEO Position: Q3 2025 in Review

Raymond James Financial sold out of NeoGenomics (NEO) in Q3 2025, closing a stake of 46,903 shares — an estimated $343K sold.

Raymond James Financial first reported a position in NEO in Q4 2024 and held it in 3 quarters. The position peaked at $839K in Q4 2024. 254 funds tracked by Wall St. Rank hold NEO as of Q3 2025.

  • Raymond James Financial reported no remaining NeoGenomics position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 46,903 NeoGenomics shares in Q3 2025, an estimated $343K.
  • Raymond James Financial first reported a position in NeoGenomics in Q4 2024 and held it in 3 quarters.
  • Raymond James Financial's NeoGenomics position peaked at $839K in Q4 2024.
  • 254 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.